NZ Hepatitis Research Review Issue 44

In this issue:  
  -  Rifaximin for alcoholic hepatitis
  -  Accuracy of point-of-care or dried blood spot analysis of HCV RNA
  -  Machine learning models to predict hepatocellular carcinoma
  -  Sustained virological response to glecaprevir/ pibrentasvir
  -  Predictors of durable functional cure after PEG-IFN
  -  Hepatitis E virus resistant to alcohol-based disinfectants
  -  Long-term renal safety with tenofovir vs entecavir
  -  Liver steatosis and liver stiffness measurement
  -  3-antigen vs a single-antigen hepatitis B vaccine 
  -  Management of HBV reactivation using HB core-related antigen assay

Please login below to download this issue (PDF)